Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New treatment for erectile dysfunction.

R T Segraves1

  • 1Department of Psychiatry, MetroHealth Medical Center, 2500 MetroHealth Drive, Cleveland, OH 44109, USA. rsegraves@metrohealth.org

Current Psychiatry Reports
|December 21, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapid ejaculation: a review of nosology, prevalence and treatment.

International journal of impotence research·2006
Same author

Treatment of premature ejaculation.

International journal of clinical practice·2006
Same author

A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine.

Clinical therapeutics·2001
Same author

Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women.

Journal of sex & marital therapy·2001
Same author

Historical and international context of nosology of female sexual disorders.

Journal of sex & marital therapy·2001
Same author

Evaluation of sexual functioning in depressed outpatients: a double-blind comparison of sustained-release bupropion and sertraline treatment.

Journal of clinical psychopharmacology·2000

Sildenafil, an oral medication, effectively treats erectile dysfunction by enhancing sexual stimulation. New agents like apomorphine also show promise, advancing the understanding of sexual function neurobiology.

Area of Science:

  • Urology
  • Psychiatry
  • Pharmacology

Background:

  • Erectile dysfunction (ED) has seen significant advancements in evaluation and treatment.
  • Multiple therapeutic options are now available for managing ED.

Purpose of the Study:

  • To review the current understanding and treatment of erectile dysfunction.
  • To highlight the impact of novel pharmacological agents on ED management and sexual function neurobiology.

Main Methods:

  • Review of current literature on erectile dysfunction treatments.
  • Discussion of the mechanism of action for sildenafil and apomorphine.
  • Analysis of clinical efficacy and patient populations.

Main Results:

  • Sildenafil, an oral vasoactive agent, has revolutionized ED treatment by blocking cyclic guanosine monophosphate degradation.

Related Experiment Videos

  • Sildenafil demonstrates efficacy across diverse patient groups, including psychiatric patients, and can reverse psychoactive agent-induced ED.
  • Emerging agents like apomorphine, a central dopamine agonist, offer new therapeutic avenues and deepen the understanding of sexual neurobiology.

    • Conclusions:

    • Sildenafil is a highly effective treatment for erectile dysfunction with broad applicability.
    • Novel agents like apomorphine are advancing the neurobiological understanding of sexual function.
    • Pharmacological interventions are crucial in managing ED and improving treatment compliance.